Astrazeneca

Astrazeneca

AstraZeneca is a worldwide biopharmaceutical company driven by science, dedicated to the discovery, development, and marketing of prescription medications. Our mission is to advance scientific boundaries to provide transformative medicines. We believe that placing science at the heart of our operations is the key to achieving our goals. Science is integral to our identity; it motivates us each day and is woven into our very essence. However, we also recognize that we don’t have all the solutions. We aim to foster a culture of idea-sharing, as we believe collaboration leads to improved medicines. This inclusive and open approach is fundamental to everything we do. We concentrate on three primary areas of therapy: Oncology, Cardiovascular & Metabolic Disease (CVMD), and Respiratory. Additionally, we are selectively involved in autoimmunity, neuroscience, and infectious diseases. To effectively push scientific boundaries, we combine our diverse capabilities, which include small molecules and biologics, as well as immunotherapies and innovative delivery systems that provide patients with options. Our commitment to personalized healthcare ensures that we match treatments to the patients who will benefit most. Our teams also collaborate with top academic and biotech research institutions to drive innovation and explore emerging technologies like Modified RNA and CRISPR genome editing.

International
English
Corporate/Government Newsroom

Outlet metrics

Domain Authority
70
Ranking

Global

#62495

United States

#43330

Health/Biotechnology and Pharmaceuticals

#32

Traffic sources
Monthly visitors

Articles

  • 3 weeks ago | astrazeneca.com

    Learn about how Healthy Heart Africa is building on a decade of success to improve patient outcomes and decrease the burden of NCDs in Africa.

  • 1 month ago | astrazeneca.com

    Learn more about our shift to 100% renewable energy sources as part of our bold climate action programme to achieve net zero

  • Oct 29, 2024 | astrazeneca.com

    Learn how we are dedicated to accelerating clinical trial diversity and eliminating long standing health disparities.

  • Sep 25, 2024 | astrazeneca.com

  • Sep 10, 2024 | astrazeneca.com

    At AstraZeneca our aim is to help improve the outcomes of breast cancer patients with the ambition to one day eliminate cancer as a cause of death.